Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Hypersensitivity × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 NET 1 Gynecologic 1 Endocrine 1

Conditions

Neuroendocrine Tumors 13 Thyroid Neoplasms 1 Thymoma 1 Teratoma 1 Sarcoma 1 Parkinson Disease 1 Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Hypersensitivity 1 Gastro-enteropancreatic neuroendocrine tumor 1 Disease 1 Carcinoma, Lobular 1 Carcinoma, Hepatocellular 1 Adenoma, Islet Cell 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01673906 2025-06-24

68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

Azienda USL Reggio Emilia - IRCCS

Phase 2 Completed

Hypersensitivity, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡